|
1
|
NIH consensus conference. Adjuvant therapy
for patients with colon and rectal cancer. JAMA. 264:1444–1450.
1990.PubMed/NCBI
|
|
2
|
Benson AB III, Schrag D, Somerfield MR,
Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J,
McAllister P, Van Cutsem E, et al: American Society of Clinical
Oncology recommendations on adjuvant chemotherapy for stage II
colon cancer. J Clin Oncol. 22:3408–3419. 2004.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Schmoll HJ, Van Cutsem E, Stein A,
Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde
CJ, Balmana J, Regula J, et al: ESMO Consensus Guidelines for
management of patients with colon and rectal cancer. a personalized
approach to clinical decision making. Ann Oncol. 23:2479–2516.
2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gill S, Loprinzi CL, Sargent DJ, Thomé SD,
Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE,
Francois Seitz J, et al: Pooled analysis of fluorouracil-based
adjuvant therapy for stage II and III colon cancer: Who benefits
and by how much? J Clin Oncol. 22:1797–1806. 2004.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Danenberg PV: Thymidylate synthetase-a
target enzyme in cancer chemotherapy. Biochim Biophys Acta.
473:73–92. 1977.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Salonga D, Danenberg KD, Johnson M,
Metzger R, Groshen S, Tsao-Wei DD, Lenz HJ, Leichman CG, Leichman
L, Diasio RB and Danenberg PV: Colorectal tumors responding to
5-fluorouracil have low gene expression levels of dihydropyrimidine
dehydrogenase, thymidylate synthase, and thymidine phosphorylase.
Clin Cancer Res. 6:1322–1327. 2000.PubMed/NCBI
|
|
7
|
Edler D, Glimelius B, Hallström M,
Jakobsen A, Johnston PG, Magnusson I, Ragnhammar P and Blomgren H:
Thymidylate synthase expression in colorectal cancer: A prognostic
and predictive marker of benefit from adjuvant fluorouracil-based
chemotherapy. J Clin Oncol. 20:1721–1728. 2002.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Soong R, Shah N, Salto-Tellez M, Tai BC,
Soo RA, Han HC, Ng SS, Tan WL, Zeps N, Joseph D, et al: Prognostic
significance of thymidylate synthase, dihydropyrimidine
dehydrogenase and thymidine phosphorylase protein expression in
colorectal cancer patients treated with or without
5-fluorouracil-based chemotherapy. Ann Oncol. 19:915–919.
2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Iacopetta B, Grieu F, Joseph D and Elsaleh
H: A polymorphism in the enhancer region of the thymidylate
synthase promoter influences the survival of colorectal cancer
patients treated with 5-fluorouracil. Br J Cancer. 85:827–830.
2001.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tsuji T, Hidaka S, Sawai T, Nakagoe T,
Yano H, Haseba M, Komatsu H, Shindou H, Fukuoka H, Yoshinaga M, et
al: Polymorphism in the thymidylate synthase promoter enhancer
region is not an efficacious marker for tumor sensitivity to
5-fluorouracil-based oral adjuvant chemotherapy in colorectal
cancer. Clin Cancer Res. 9:3700–3704. 2003.PubMed/NCBI
|
|
11
|
Scartozzi M, Maccaroni E, Giampieri R,
Pistelli M, Bittoni A, Del Prete M, Berardi R and Cascinu S:
5-Fluorouracil pharmacogenomics: Still rocking after all these
years? Pharmacogenomics. 12:251–265. 2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Horie N, Aiba H, Oguro K, Hojo H and
Takeishi K: Functional analysis and DNA polymorphism of the
tandemly repeated sequences in the 5'-terminal regulatory region of
the human gene for thymidylate synthase. Cell Struct Funct.
20:191–197. 1995.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mandola MV, Stoehlmacher J, Muller-Weeks
S, Cesarone G, Yu MC, Lenz HJ and Ladner RD: A novel single
nucleotide polymorphism within the 5'tandem repeat polymorphism of
the thymidylate synthase gene abolishes USF-1 binding and alters
transcriptional activity. Cancer Res. 63:2898–2904. 2003.PubMed/NCBI
|
|
14
|
Kawakami K and Watanabe G: Identification
and functional analysis of single nucleotide polymorphism in the
tandem repeat sequence of thymidylate synthase gene. Cancer Res.
63:6004–6007. 2003.PubMed/NCBI
|
|
15
|
Kawakami K, Omura K, Kanehira E and
Watanabe Y: Polymorphic tandem repeats in the thymidylate synthase
gene is associated with its protein expression in human
gastrointestinal cancers. Anticancer Res. 19:3249–3252.
1999.PubMed/NCBI
|
|
16
|
Kawakami K, Salonga D, Park JM, Danenberg
KD, Uetake H, Brabender J, Omura K, Watanabe G and Danenberg PV:
Different lengths of a polymorphic repeat sequence in the
thymidylate synthase gene affect translational efficiency but not
its gene expression. Clin Cancer Res. 7:4096–4101. 2001.PubMed/NCBI
|
|
17
|
Lincz LF, Scorgie FE, Garg MB and Ackland
SP: Identification of a novel single nucleotide polymorphism in the
first tandem repeat sequence of the thymidylate synthase 2R allele.
Int J Cancer. 120:1930–1934. 2007.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kawakami K, Ishida Y, Danenberg KD, Omura
K, Watanabe G and Danenberg PV: Functional polymorphism of the
thymidylate synthase gene in colorectal cancer accompanied by
frequent loss of heterozygosity. Jpn J Cancer Res. 93:1221–1229.
2002.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Uchida K, Hayashi K, Kawakami K, Schneider
S, Yochim JM, Kuramochi H, Takasaki K, Danenberg KD and Danenberg
PV: Loss of heterozygosity at the thymidylate synthase (TS) locus
on chromosome 18 affects tumor response and survival in individuals
heterozygous for a 28-bp polymorphism in the TS gene. Clin Cancer
Res. 10:433–439. 2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jen J, Kim H, Piantadosi S, Liu ZF, Levitt
RC, Sistonen P, Kinzler KW, Vogelstein B and Hamilton SR: Allelic
loss of chromosome 18q and prognosis in colorectal cancer. N Engl J
Med. 331:213–221. 1994.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lanza G, Matteuzzi M, Gafá R, Orvieto E,
Maestri I, Santini A and del Senno L: Chromosome 18q allelic loss
and prognosis in stage II and III colon cancer. Int J Cancer.
79:390–395. 1998.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Marsh S, Collie Duguid ES, Li T, Liu X and
McLeod HL: Ethnic variation in the thymidylate synthase enhancer
region polymorphism among Caucasian and Asian populations.
Genomics. 58:310–312. 1999.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ogunbiyi OA, Goodfellow PJ, Herfarth K,
Gagliardi G, Swanson PE, Birnbaum EH, Read TE, Fleshman JW, Kodner
IJ and Moley JF: Confirmation that chromosome 18q allelic loss in
colon cancer is a prognostic indicator. J Clin Oncol. 16:427–433.
1998.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Watanabe T, Wu TT, Catalano PJ, Ueki T,
Satriano R, Haller DG, Benson AB III and Hamilton SR: Molecular
predictors of survival after adjuvant chemotherapy for colon
cancer. N Engl J Med. 344:1196–1206. 2001.PubMed/NCBI View Article : Google Scholar
|
